Labonté P - Search Results

1

Statins can exert dual, concentration dependent effects on HCV entry in vitro.

Blanchet M, Le QT, Seidah NG, Labonté P. Blanchet M, et al. Among authors: labonte p. Antiviral Res. 2016 Apr;128:43-8. doi: 10.1016/j.antiviral.2016.02.006. Epub 2016 Feb 8. Antiviral Res. 2016. PMID: 26868875

2

Emerging viruses: risk of pandemic.

Labonté P, Seidah NG. Labonté P, et al. Expert Rev Anti Infect Ther. 2008 Oct;6(5):581-3. doi: 10.1586/14787210.6.5.581. Expert Rev Anti Infect Ther. 2008. PMID: 18847397

3

PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 expression.

Labonté P, Begley S, Guévin C, Asselin MC, Nassoury N, Mayer G, Prat A, Seidah NG. Labonté P, et al. Hepatology. 2009 Jul;50(1):17-24. doi: 10.1002/hep.22911. Hepatology. 2009. PMID: 19489072

4

Novel HCV replication mouse model using human hepatocellular carcinoma xenografts.

Guévin C, Lamarre A, Labonté P. Guévin C, et al. Among authors: labonte p. Antiviral Res. 2009 Oct;84(1):14-22. doi: 10.1016/j.antiviral.2009.07.009. Epub 2009 Jul 19. Antiviral Res. 2009. PMID: 19622372

5

SKI-1/S1P inhibition: a promising surrogate to statins to block hepatitis C virus replication.

Blanchet M, Seidah NG, Labonté P. Blanchet M, et al. Among authors: labonte p. Antiviral Res. 2012 Aug;95(2):159-66. doi: 10.1016/j.antiviral.2012.05.006. Epub 2012 May 22. Antiviral Res. 2012. PMID: 22626636 Review.

6

Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle.

Blanchet M, Sureau C, Labonté P. Blanchet M, et al. Among authors: labonte p. Antiviral Res. 2014 Jun;106:111-5. doi: 10.1016/j.antiviral.2014.03.017. Epub 2014 Apr 6. Antiviral Res. 2014. PMID: 24717262

7

SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection.

Blanchet M, Sureau C, Guévin C, Seidah NG, Labonté P. Blanchet M, et al. Among authors: labonte p. Antiviral Res. 2015 Mar;115:94-104. doi: 10.1016/j.antiviral.2014.12.017. Epub 2015 Jan 5. Antiviral Res. 2015. PMID: 25573299

8

Plasma Membrane Tetraspanin CD81 Complexes with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR), and Its Levels Are Reduced by PCSK9.

Le QT, Blanchet M, Seidah NG, Labonté P. Le QT, et al. Among authors: labonte p. J Biol Chem. 2015 Sep 18;290(38):23385-400. doi: 10.1074/jbc.M115.642991. Epub 2015 Jul 20. J Biol Chem. 2015. PMID: 26195630 Free PMC article.

9

LC3B is not recruited along with the autophagy elongation complex (ATG5-12/16L1) at HCV replication site and is dispensable for viral replication.

Fahmy AM, Khabir M, Blanchet M, Labonté P. Fahmy AM, et al. Among authors: labonte p. PLoS One. 2018 Oct 4;13(10):e0205189. doi: 10.1371/journal.pone.0205189. eCollection 2018. PLoS One. 2018. PMID: 30286180 Free PMC article.

10

Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells.

Blanchet M, Sinnathamby V, Vaillant A, Labonté P. Blanchet M, et al. Among authors: labonte p. Antiviral Res. 2019 Apr;164:97-105. doi: 10.1016/j.antiviral.2019.02.009. Epub 2019 Feb 13. Antiviral Res. 2019. PMID: 30771404

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page